- Home
- MAIA vs PRT Comparison
MAIA vs PRT Comparison
Compare MAIA & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MAIA | PRT |
|---|---|---|
| Founded | 2018 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.3M | 46.7M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | MAIA | PRT |
|---|---|---|
| Price | $2.16 | $3.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 622.1K | 105.5K |
| Earning Date | 11-07-2025 | 11-13-2025 |
| Dividend Yield | N/A | ★ 13.77% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | N/A | ★ $6,009,225.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.29 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.87 | $2.61 |
| 52 Week High | $2.74 | $4.63 |
Technical Indicators
Market Signals| Indicator | MAIA | PRT |
|---|---|---|
| Relative Strength Index (RSI) | 74.91 | 42.07 |
| Support Level | $1.49 | $2.73 |
| Resistance Level | $1.71 | $3.23 |
| Average True Range (ATR) | 0.16 | 0.14 |
| MACD | 0.04 | 0.06 |
| Stochastic Oscillator | 99.99 | 62.10 |
Price Performance
Historical ComparisonAbout MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About PRT PermRock Royalty Trust Trust Units
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.